+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CBD Consumer Health Market - Global Forecast 2026-2032- Product Image
CBD Consumer Health Market - Global Forecast 2026-2032- Product Image
Sale

CBD Consumer Health Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337466
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The CBD Consumer Health Market is projected to reach USD 16.62 Billion in 2026. It is expected to continue growing at a CAGR of 16.35%, reaching USD 41.56 Billion by 2032.

The CBD consumer health market is evolving from a high-growth wellness category into a more regulated, evidence-led segment of consumer healthcare. Cannabidiol, or CBD, is a non-intoxicating cannabinoid derived from cannabis or hemp; the World Health Organization has reported that pure CBD does not appear to have abuse or dependence potential, while the U.S. FDA has approved a purified CBD medicine for specific rare seizure disorders. These verified facts continue to shape consumer trust, product positioning, and regulatory scrutiny.

Demand is being driven by consumers seeking non-intoxicating wellness formats across oils, capsules, topicals, edibles, beverages, and personal care products. However, the category’s long-term value depends on quality assurance, accurate labeling, contaminant testing, responsible claims, and market-specific compliance. Brands that combine CBD consumer health innovation with transparent sourcing, clinical-grade documentation, and digital education are best positioned to compete in a crowded marketplace.

Transformative Shifts in the CBD Consumer Health Landscape

The landscape is being reshaped by regulation, retail consolidation, and a clear shift from novelty purchasing to trust-based purchasing. In the United States, hemp-derived CBD expanded after the 2018 Farm Bill defined hemp as cannabis containing not more than 0.3% delta-9 THC on a dry-weight basis, but FDA restrictions on CBD in foods and dietary supplements continue to influence channel strategy. In Europe, CBD extracts are generally assessed through the Novel Food framework, making authorization pathways central to commercialization.

Consumer expectations are also changing. Shoppers increasingly compare certificates of analysis, THC content, extraction methods, ingredient transparency, and sustainability claims before purchase. This is pushing CBD consumer health companies toward pharmaceutical-style quality systems, validated supply chains, and stronger post-market monitoring. At the same time, mainstream retailers and digital marketplaces are tightening standards, favoring compliant brands with defensible claims over unverified wellness messaging.

Cumulative Impact of Artificial Intelligence on CBD Consumer Health

Artificial intelligence is becoming a cumulative force across the CBD consumer health value chain. AI-enabled demand forecasting helps brands align inventory with fast-moving formats such as gummies, tinctures, topicals, and functional beverages, reducing stockouts and overproduction. Machine learning can also support supplier risk scoring by analyzing laboratory results, pesticide screenings, heavy-metal data, and batch consistency across cultivation and extraction partners.

AI is particularly valuable in regulatory intelligence and consumer engagement. Natural language processing can monitor changes in FDA communications, European Novel Food decisions, Health Canada rules, and advertising standards, helping teams update claims and packaging faster. In eCommerce, AI-driven personalization can improve product education, but responsible governance is essential: brands must avoid disease-treatment claims for non-approved products and ensure that chatbot responses, recommendation engines, and influencer content remain compliant.

Key Regional Insights for CBD Consumer Health

North America remains the most visible CBD consumer health region because of the United States’ large hemp supply base, advanced direct-to-consumer channels, and extensive retail experimentation, while Canada’s federally regulated cannabis system provides a structured national framework for cannabinoid products. Latin America is developing through medical cannabis programs, court decisions, and hemp policy discussions, with Brazil and Mexico drawing attention for consumer scale, pharmacy-based access, and evolving healthcare pathways.

Europe is defined by a more cautious and documentation-heavy approach, especially through Novel Food assessments, cosmetics requirements, and national enforcement differences across the European Union and the United Kingdom. Asia-Pacific presents long-term potential but fragmented regulation; Japan has permitted certain CBD products under strict THC controls, Australia manages access through therapeutic goods pathways, and China is important in hemp cultivation and ingredient supply despite tighter domestic cannabis controls. The Middle East and Africa are earlier-stage markets, with GCC jurisdictions taking conservative positions and selected African economies exploring cannabis cultivation, export, or medical frameworks.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, CBD consumer health opportunities are shaped by rapid wellness adoption but constrained by strict narcotics laws and uneven cannabis reforms; Thailand’s policy changes created regional attention, while neighboring markets remain cautious and enforcement-sensitive. The GCC is characterized by high purchasing power and sophisticated healthcare retail, yet conservative drug-control regimes require extreme caution for CBD market entry, product movement, labeling, and digital promotion.

The European Union is a key regulatory benchmark because Novel Food review, cosmetics rules, and THC thresholds influence global compliance strategies. BRICS economies represent a mixed opportunity set: China and India offer scale and botanical supply-chain relevance, Brazil is advancing cannabis-based health access, Russia remains restrictive, and South Africa has become an important African policy reference point. G7 markets are central to premium CBD consumer health demand, research standards, and multinational retail entry, while NATO members overlap heavily with North American and European jurisdictions where traceability, safety, and advertising compliance are strategic requirements.

Key Country Insights for CBD Consumer Health

The United States leads CBD consumer health visibility, but companies must navigate the gap between hemp legality and FDA limits on ingestible CBD claims. Canada offers a national cannabis framework, while Mexico and Brazil are important Latin American markets with evolving legal access and strong long-term consumer potential. In Europe, the United Kingdom, Germany, France, Italy, and Spain are important demand centers, though CBD rules differ by product type, THC limit, Novel Food status, cosmetics use, and local enforcement. Russia remains a restrictive market with limited CBD consumer health opportunity compared with Western Europe.

In Asia-Pacific, China is significant for hemp cultivation and ingredient processing but highly restrictive on domestic cannabis consumer products. India has a long history of hemp and cannabis-related traditional use, yet modern CBD commercialization is highly dependent on state and national controls. Japan permits carefully controlled CBD products with strict THC expectations, Australia regulates cannabinoid access through therapeutic goods channels, and South Korea maintains tight cannabis controls with limited medical exceptions. These country-level differences make localized compliance, labeling, testing, claims substantiation, and distribution strategy essential.

Actionable Recommendations for CBD Consumer Health Leaders

Industry leaders should prioritize compliance-by-design, beginning with product classification, THC limits, ingredient approvals, claims review, and market-by-market advertising controls before launch. Every batch should be supported by third-party certificates of analysis covering cannabinoid potency, residual solvents, pesticides, heavy metals, microbial contamination, and THC compliance.

Companies should invest in differentiated, evidence-aligned formats rather than broad wellness claims. Topicals, cosmetics, sleep-adjacent products, functional formulations, and pharmacist-supported education can help build trust when claims are conservative and substantiated. Leaders should also use AI for regulatory monitoring, demand forecasting, and quality analytics while maintaining human review for claims, labeling, and consumer safety communications.

Research Methodology

This executive summary is developed using a secondary research methodology grounded in publicly available regulatory, scientific, and industry sources. Core inputs include government and intergovernmental materials from agencies such as the U.S. FDA, USDA, Health Canada, the European Commission, the World Health Organization, and national cannabis or therapeutic goods authorities. The analysis also considers published policy frameworks, product safety expectations, market-entry requirements, and observed retail and eCommerce trends.

Insights were synthesized through cross-regional comparison, regulatory triangulation, and qualitative assessment of supply-chain, consumer, and technology drivers. Emphasis was placed on verified facts, including legal definitions, approval pathways, known regulatory constraints, and established safety considerations. Market interpretation avoids unsupported medical claims and focuses on commercially relevant, evidence-led implications for CBD consumer health stakeholders.

Conclusion

The CBD consumer health market is moving toward a more disciplined phase in which trust, safety, and regulatory readiness determine competitive advantage. Consumer interest remains strong, but the leading brands will be those that combine transparent sourcing, rigorous testing, responsible claims, and market-specific compliance with accessible education.

Artificial intelligence, digital commerce, and global wellness demand will continue to influence the category, but they will not replace the need for scientific credibility and regulatory discipline. Companies that build evidence-led portfolios and adaptable compliance systems can capture long-term value as CBD consumer health matures across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. CBD Consumer Health Market, by Product Type
7.1. Introduction
7.2. Capsules
7.2.1. Softgels
7.2.2. Tablets
7.3. Edibles
7.3.1. Gummies
7.3.2. Chocolates
7.3.3. Candies
7.3.4. Snacks
7.4. Oils
7.5. Topicals
7.5.1. Balms & Salves
7.5.2. Creams & Lotions
7.5.3. Patches
7.6. Beverages
7.6.1. Water
7.6.2. Tea
7.6.3. Coffee
7.6.4. Energy Drinks
8. CBD Consumer Health Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Solid
9. CBD Consumer Health Market, by Spectrum Types
9.1. Introduction
9.2. Full Spectrum CBD
9.3. Broad Spectrum CBD
10. CBD Consumer Health Market, by Application
10.1. Introduction
10.2. Mental Health
10.2.1. Anxiety
10.2.2. Stress
10.2.3. Depression
10.3. Neurological Disorders
10.3.1. Epilepsy
10.3.2. Parkinson’s Support
10.4. Pain Management
10.4.1. Chronic Pain
10.4.2. Arthritis Pain
10.4.3. Muscle Pain
10.5. Skin Care
10.5.1. Acne
10.5.2. Eczema
10.5.3. Psoriasis
10.6. Sleep Disorders
11. CBD Consumer Health Market, by End User
11.1. Introduction
11.2. Humans
11.2.1. Adults
11.2.2. Elderly
11.3. Animals
11.3.1. Dogs
11.3.2. Cats
12. CBD Consumer Health Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. CBD Consumer Health Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. CBD Consumer Health Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Ananta Hemp Works
16.2. Awshad
16.3. Bluebird Botanicals
16.4. Bombay Hemp Company Private Limited
16.5. Cannarma
16.6. CBD American Shaman, LLC
16.7. cbdMD, Inc.
16.8. Charlotte's Web Holdings, Inc.
16.9. Cornbread Hemp
16.10. CV Sciences, Inc.
16.11. Elixinol Wellness Ltd.
16.12. Endoca BV
16.13. Fab Nutrition, LLC
16.14. Folium Biosciences
16.15. Green Roads LLC
16.16. HempCann Solutions Private Limited
16.17. India Hemp Organics
16.18. Joy Organics, LLC
16.19. Kazmira LLC
16.20. Lazarus Naturals
16.21. Medical Marijuana, Inc.
16.22. Medterra CBD, LLC
16.23. NuLeaf Naturals, LLC
16.24. PharmaHemp d.o.o.
16.25. Pure Hemp Botanicals
17. Key Experts
List of Figures
FIGURE 1. Global CBD Consumer Health Market, Years Considered for the Study
FIGURE 2. Global CBD Consumer Health Market, Research Design
FIGURE 3. Global CBD Consumer Health Market, Research Framework
FIGURE 4. Global CBD Consumer Health Market, Data Triangulation
FIGURE 5. Global CBD Consumer Health Market Size, 2017-2032 (USD Million)
FIGURE 6. Global CBD Consumer Health Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global CBD Consumer Health Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global CBD Consumer Health Market Size, by Form, 2025 vs 2032 (%)
FIGURE 9. Global CBD Consumer Health Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global CBD Consumer Health Market Size, by Spectrum Types, 2025 vs 2032 (%)
FIGURE 11. Global CBD Consumer Health Market Size, by Spectrum Types, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global CBD Consumer Health Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global CBD Consumer Health Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global CBD Consumer Health Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global CBD Consumer Health Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global CBD Consumer Health Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global CBD Consumer Health Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global CBD Consumer Health Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global CBD Consumer Health Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global CBD Consumer Health Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global CBD Consumer Health Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global CBD Consumer Health Market Segmentation & Coverage
TABLE 2. Global CBD Consumer Health Market Size, 2017-2032 (USD Million)
TABLE 3. Global CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Softgels Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Softgels Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Softgels Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Edibles Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Edibles Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Edibles Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Gummies Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Gummies Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Gummies Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Chocolates Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Chocolates Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Chocolates Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Candies Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Candies Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Candies Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Snacks Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Snacks Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Snacks Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Oils Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Oils Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Oils Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Topicals Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Topicals Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Topicals Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Balms & Salves Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Balms & Salves Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Balms & Salves Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Creams & Lotions Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Creams & Lotions Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Creams & Lotions Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Tea Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Tea Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Tea Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Coffee Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Coffee Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Coffee Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Energy Drinks Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Energy Drinks Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Energy Drinks Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 59. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 66. Global Full Spectrum CBD Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Full Spectrum CBD Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Full Spectrum CBD Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Broad Spectrum CBD Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Broad Spectrum CBD Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Broad Spectrum CBD Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Global Mental Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Mental Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Mental Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Anxiety Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Anxiety Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Anxiety Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Stress Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Stress Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Stress Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Depression Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Depression Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Depression Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Neurological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Neurological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Neurological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Parkinson’s Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Parkinson’s Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Parkinson’s Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Chronic Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Chronic Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Chronic Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Arthritis Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Arthritis Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Arthritis Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Muscle Pain Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Muscle Pain Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Muscle Pain Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Skin Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Skin Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Skin Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Acne Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Acne Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Acne Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Eczema Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Eczema Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Eczema Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Sleep Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Sleep Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Sleep Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Global Humans Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Humans Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Humans Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Elderly Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Elderly Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Elderly Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 157. North America CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. North America CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. North America CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 160. North America CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 161. North America CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 162. North America CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 163. North America CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 164. North America CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 165. North America CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. North America CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 167. North America CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 168. North America CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 169. North America CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 170. North America CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. North America CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 172. North America CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 173. Latin America CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Latin America CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Latin America CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 176. Latin America CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 177. Latin America CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 178. Latin America CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 179. Latin America CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 180. Latin America CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 181. Latin America CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Latin America CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 183. Latin America CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 184. Latin America CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 185. Latin America CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 186. Latin America CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Latin America CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 188. Latin America CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 189. Europe CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Europe CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Europe CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 192. Europe CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 193. Europe CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 194. Europe CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 195. Europe CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 196. Europe CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 197. Europe CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Europe CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 199. Europe CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 200. Europe CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 201. Europe CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 202. Europe CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Europe CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 204. Europe CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 205. Middle East CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Middle East CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. Middle East CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 208. Middle East CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 209. Middle East CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 210. Middle East CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 211. Middle East CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 212. Middle East CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 213. Middle East CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Middle East CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 215. Middle East CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 216. Middle East CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 217. Middle East CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 218. Middle East CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Middle East CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 220. Middle East CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 221. Africa CBD Consumer Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Africa CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Africa CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 224. Africa CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 225. Africa CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 226. Africa CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 227. Africa CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 228. Africa CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 229. Africa CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Africa CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 231. Africa CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 232. Africa CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 233. Africa CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 234. Africa CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Africa CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 236. Africa CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 237. Global CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. ASEAN CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. ASEAN CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. ASEAN CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 241. ASEAN CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 242. ASEAN CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 243. ASEAN CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 244. ASEAN CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 245. ASEAN CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 246. ASEAN CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. ASEAN CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 248. ASEAN CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 249. ASEAN CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 250. ASEAN CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 251. ASEAN CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. ASEAN CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 253. ASEAN CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 254. GCC CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. GCC CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. GCC CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 257. GCC CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 258. GCC CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 259. GCC CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 260. GCC CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 261. GCC CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 262. GCC CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. GCC CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 264. GCC CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 265. GCC CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 266. GCC CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 267. GCC CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. GCC CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 269. GCC CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 270. European Union CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. European Union CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. European Union CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 273. European Union CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 274. European Union CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 275. European Union CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 276. European Union CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 277. European Union CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 278. European Union CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. European Union CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 280. European Union CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 281. European Union CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 282. European Union CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 283. European Union CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. European Union CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 285. European Union CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 286. BRICS CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 287. BRICS CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. BRICS CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 289. BRICS CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 290. BRICS CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 291. BRICS CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 292. BRICS CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 293. BRICS CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 294. BRICS CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. BRICS CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 296. BRICS CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 297. BRICS CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 298. BRICS CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 299. BRICS CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. BRICS CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 301. BRICS CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 302. G7 CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. G7 CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. G7 CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 305. G7 CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 306. G7 CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 307. G7 CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 308. G7 CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 309. G7 CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 310. G7 CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. G7 CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 312. G7 CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 313. G7 CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 314. G7 CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 315. G7 CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. G7 CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 317. G7 CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 318. NATO CBD Consumer Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 319. NATO CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 320. NATO CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 321. NATO CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 322. NATO CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 323. NATO CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 324. NATO CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 325. NATO CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 326. NATO CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. NATO CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 328. NATO CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 329. NATO CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 330. NATO CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 331. NATO CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. NATO CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 333. NATO CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 334. Global CBD Consumer Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 335. United States CBD Consumer Health Market Size, 2017-2032 (USD Million)
TABLE 336. United States CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 337. United States CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 338. United States CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 339. United States CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 340. United States CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 341. United States CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 342. United States CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 343. United States CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 344. United States CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 345. United States CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 346. United States CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 347. United States CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 348. United States CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. United States CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 350. United States CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 351. Canada CBD Consumer Health Market Size, 2017-2032 (USD Million)
TABLE 352. Canada CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 353. Canada CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 354. Canada CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 355. Canada CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 356. Canada CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 357. Canada CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 358. Canada CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 359. Canada CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 360. Canada CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 361. Canada CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 362. Canada CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 363. Canada CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 364. Canada CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 365. Canada CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 366. Canada CBD Consumer Health Market Size, by Animals, 2017-2032 (USD Million)
TABLE 367. Mexico CBD Consumer Health Market Size, 2017-2032 (USD Million)
TABLE 368. Mexico CBD Consumer Health Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 369. Mexico CBD Consumer Health Market Size, by Capsules, 2017-2032 (USD Million)
TABLE 370. Mexico CBD Consumer Health Market Size, by Edibles, 2017-2032 (USD Million)
TABLE 371. Mexico CBD Consumer Health Market Size, by Topicals, 2017-2032 (USD Million)
TABLE 372. Mexico CBD Consumer Health Market Size, by Beverages, 2017-2032 (USD Million)
TABLE 373. Mexico CBD Consumer Health Market Size, by Form, 2017-2032 (USD Million)
TABLE 374. Mexico CBD Consumer Health Market Size, by Spectrum Types, 2017-2032 (USD Million)
TABLE 375. Mexico CBD Consumer Health Market Size, by Application, 2017-2032 (USD Million)
TABLE 376. Mexico CBD Consumer Health Market Size, by Mental Health, 2017-2032 (USD Million)
TABLE 377. Mexico CBD Consumer Health Market Size, by Neurological Disorders, 2017-2032 (USD Million)
TABLE 378. Mexico CBD Consumer Health Market Size, by Pain Management, 2017-2032 (USD Million)
TABLE 379. Mexico CBD Consumer Health Market Size, by Skin Care, 2017-2032 (USD Million)
TABLE 380. Mexico CBD Consumer Health Market Size, by End User, 2017-2032 (USD Million)
TABLE 381. Mexico CBD Consumer Health Market Size, by Humans, 2017-2032 (USD Million)
TABLE 382. Mexico CBD Consumer Health Ma

Companies Mentioned

  • Ananta Hemp Works
  • Awshad
  • Bluebird Botanicals
  • Bombay Hemp Company Private Limited
  • Cannarma
  • CBD American Shaman, LLC
  • cbdMD, Inc.
  • Charlotte's Web Holdings, Inc.
  • Cornbread Hemp
  • CV Sciences, Inc.
  • Elixinol Wellness Ltd.
  • Endoca BV
  • Fab Nutrition, LLC
  • Folium Biosciences
  • Green Roads LLC
  • HempCann Solutions Private Limited
  • India Hemp Organics
  • Joy Organics, LLC
  • Kazmira LLC
  • Lazarus Naturals
  • Medical Marijuana, Inc.
  • Medterra CBD, LLC
  • NuLeaf Naturals, LLC
  • PharmaHemp d.o.o.
  • Pure Hemp Botanicals

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.62 Billion
Forecasted Market Value ( USD ) by 2032 $ 41.56 Billion
Compound Annual Growth Rate16.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

CBD Oil and CBD Consumer Health Market Report 2026 - Product Image

CBD Oil and CBD Consumer Health Market Report 2026

  • Report
  • 250 Pages
  • Global
From
CBD Consumer Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

CBD Consumer Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Cannabidiol Consumer Health Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Cannabidiol Consumer Health Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Tobacco Alternative Gums Market Report 2026 - Product Image

Tobacco Alternative Gums Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sleep Aids Market - Global Strategic Business Report - Product Image

Sleep Aids Market - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From

About the Market

The CBD Product market within the context of Analgesics is a rapidly growing industry. CBD products are used to treat a variety of conditions, including chronic pain, inflammation, and anxiety. CBD products are becoming increasingly popular as an alternative to traditional analgesics, such as opioids, due to their lack of side effects and potential for fewer risks of addiction. CBD products are available in a variety of forms, including oils, tinctures, edibles, and topical creams. CBD products are becoming increasingly popular due to their potential to provide relief from pain and inflammation without the risk of addiction or other side effects associated with traditional analgesics. As the market continues to grow, more companies are entering the space, offering a variety of products to meet the needs of consumers. Some of the companies in the market include Charlotte's Web, Green Roads, CBDfx, and PureKana. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.